Cdc7 Kinase Regulation in DNA Replication

Cdc7 kinase, in complex with its regulatory subunit Dbf4, orchestrates the initiation of eukaryotic DNA replication by phosphorylating components of the Mcm2–7 helicase complex at replication origins. Activation of Cdc7–Dbf4 drives origin firing during early S phase, while checkpoint pathways centred on ATR kinase modulate its activity under genotoxic stress to prevent excess or unscheduled initiation events. Reciprocal regulation between Cdc7–Dbf4 and phosphatases such as Rif1–PP1 ensures temporal control of origin activation across the genome. Dysregulation of this balance can lead to replication stress, genomic instability and contributes to tumourigenesis, making Cdc7 both a fundamental cell-cycle regulator and an emerging therapeutic target.

Research from Nature Portfolio

Recent studies have demonstrated that selective inhibition of Cdc7 induces replication stress leading to senescence-associated secretory phenotype (SASP) and heightened antitumour immunity. Preclinical models reveal that the Cdc7 inhibitor TAK-931 generates aneuploid cells that secrete inflammatory cytokines, recruit immune infiltrates and synergise with immune checkpoint blockade to enhance tumour control. Foundational work has also elucidated how ATR kinase inhibition provokes unscheduled origin firing via Cdc7-dependent phosphorylation of GINS subunits, identifying novel phosphorylations that promote GINS–And-1 association and revealing the interplay between checkpoint and initiation kinases. Additional investigations into Dbf4 zinc-finger motifs in hepatocellular carcinoma have uncovered how altered Dbf4 expression modulates Cdc7 activity and downstream ERBB-MAPK signalling, underscoring the oncogenic potential of Cdc7 regulation.

Cdc7 Kinase Regulation in DNA Replication publication trend

The graph below shows the total number of articles in cdc7 kinase regulation in dna replication across all publications each year (not limited to Nature Index journals).

Technical terms

Cdc7 kinase: A serine/threonine kinase that, when bound to Dbf4, phosphorylates Mcm2–7 subunits to trigger replication origin activation.

Dbf4: Regulatory subunit of Cdc7 that confers substrate specificity and cell-cycle timing to the kinase complex.

Replication origin firing: Coordinated activation of licensed DNA start sites by kinases to assemble active replication forks in S phase.

Replication stress: Conditions that impede replication-fork progression, leading to stalled forks, genomic instability and checkpoint activation.

Senescence-associated secretory phenotype (SASP): Proinflammatory cytokine and chemokine secretion by senescent cells that can modulate immune surveillance.

Allosteric modulator: A compound that binds a site distinct from the enzyme’s active centre to alter its activity or substrate interactions.

ATR kinase: A DNA damage–responsive checkpoint kinase that limits origin firing and stabilises replication forks under stress.

Replication protein A (RPA): A single-stranded DNA-binding complex essential for DNA replication, repair and checkpoint signalling.

References

1. CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade. Nature Communications (2023).
2. Identifying CDC7 as a synergistic target of chemotherapy in resistant small-cell lung cancer via CRISPR/Cas9 screening. Cell Death Discovery (2023).
3. Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of Enzyme Inhibition and Medicinal Chemistry (2024).
4. PTBP1 enforces ATR-CHK1 signaling determining the potency of CDC7 inhibitors. iScience (2023).
5. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma. Scientific Reports (2024).
6. ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1. Nature Communications (2017).